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Daniel R. Turner, MD, Edwin Rodriguez-Cruz, MD, Robert D. Ross, MD, Thomas J. Forbes,* MD
The original Palmaz balloon expandable stent has been used extensively for the treat-
ment of vascular stenoses in older children and young adults. Placement of the Palmaz
stent in infants and small children, however, is limited by stent inflexibility, large delivery
sheath size, and concerns about creating fixed obstructions after the placement of small
diameter stents in growing patients. New Palmaz Corinthian stents were placed through
6 French sheaths in four high-risk patients with postoperative right ventricular outflow
obstruction. Patients were not considered candidates for surgical repair. Median patient
age and weight were 17 months (range 5–32 months) and 7.7 kg (range 4.6–11.1 kg),
respectively. Median fluoroscopy time was 58.2 min (range 55.2–172 min). No complica-
tions were encountered. In each case, successful stent placement was achieved, and
surgery with cardiopulmonary bypass was avoided. Palmaz Corinthian stents are more
flexible, require a smaller delivery sheath, have equal or increased radial strength, and
can be maximally expanded to a greater cross sectional area when compared to the
original Palmaz stent. These characteristics make the Palmaz Corinthian stent a reason-
able alternative for use in a select group of infants and small children who are not
candidates for surgical repair of postoperative right ventricular outflow obstruction.
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INTRODUCTION
Cardiologists have used balloon expandable intravas-
cular stents since the late 1980s to treat atherosclerotic
vascular stenoses in adults [1]. In 1991, stent technology
was reported for the treatment of congenital and postop-
erative vascular stenoses in children [2]. Since that time,
balloon expandable stents have been used successfully
by pediatric cardiologists for the treatment of both right
and left sided cardiac lesions.
The Palmaz balloon expandable stent (Johnson &
Johnson Interventional Systems, Sommerville, NJ) has
been used extensively to treat congenital and postopera-
tive right ventricular outflow obstructions in children and
adults [3–8]. Although it is technically possible to place
the original Palmaz stent in smaller patients [9], stent
placement in this group is limited by stent inflexibility,
large delivery sheath size, and the inability to dilate the
smaller, shorter Palmaz stents to near adult vessel diam-
eter.
The Palmaz Corinthian stent (Cordis Endovascular,
Johnson and Johnson, Warren, NJ) is a recent addition to
the interventional catheterization laboratory (Fig. 1). The
stent is more flexible, may be delivered through smaller
sheaths, and may be dilated to a greater maximal diam-
eter when compared to the original Palmaz stent [10].
These characteristics make the Palmaz Corinthian stent
attractive for use in infants and small children after
carefully considering the risks and benefits of stent place-
ment vs. surgery. This report describes our initial expe-
rience with the Palmaz Corinthian stent in a select group
of infants and small children with postoperative right
ventricular outflow obstruction.
TECHNIQUE
Stent placement was performed under general anesthe-
sia. Standard percutaneous technique was used to access
the femoral vessels or the internal jugular vein. Complete
right and left heart catheterizations and angiograms were
performed. The decision for stent placement was made
after reviewing the case and angiograms with the pedi-
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atric cardiac surgeon to determine the risk and benefit of
surgical vs. transcatheter management. Stent placement
was selected if the patient was considered very high risk
for surgery, or if surgery was undesirable due to multiple
previous or anticipated surgical procedures. Predilation
of the stenosis was necessary to facilitate placement of
the delivery sheath. A 5 mm3 2 cm Power Flex balloon
catheter (Cordis Endovascular) was advanced over a
0.035 inch Rosen wire (Cook Corp., Bloomington, IN)
and balloon dilation of the stenotic area(s) was per-
formed. In Patients 1–3, a 6 French, 55 cm Brite-tipped
sheath (Cordis Endovascular) was advanced over the
angioplasty catheter and positioned across the stenotic
area. In Patient 3, the Brite-tipped sheath kinked in the
right ventricular outflow tract, making stent placement
difficult. To decrease the likelihood of kinking, a 6
French, 45 cm Cook Flexor sheath (Cook Corp.) was
used in Patient 4. In each case, an end-hole catheter was
advanced through the delivery sheath over the 0.035 inch
Rosen wire. The Rosen wire was exchanged for a 0.018
inch standard wire. The Palmaz Corinthian stents were
loaded onto high pressure Jupiter 5–6 mm3 2 cm
balloon angioplasty catheters (Cordis Endovascular). The
Jupiter balloon catheters tracked easily over the
0.018 inch wire and were maneuvered without difficulty
through tightly curved delivery sheaths (Fig. 2). Stents
were deployed using 12–14 atmospheres of pressure.
Repeat hemodynamic measurements and angiograms
were obtained after stent placement, however measure-
ment of pressure gradient was not attempted if distal wire
position was lost during catheter manipulation. Heparin
was used during the procedure to keep the activated
clotting time greater than 250 sec. Intravenous cefazolin
was administered before stent deployment and for three
additional doses. On the following day, a chest X-ray was
obtained to document stent position, and aspirin was
begun at 5 mg/kg/day.
CASE SERIES
Results
From November 1999 to March 2000, 5 Palmaz Corin-
thian stents were placed in 3 infants and 1 small child
who were not considered candidates for surgery. Each
stent was deployed in the desired position. Median pa-
tient age and weight were 17 months (range 5–32
months) and 7.7 kg (range 4.6–11.1 kg), respectively.
Hemodynamics are summarized in Table I. Median flu-
oroscopy time was 58.2 min (range 55.2–172 minutes).
No complications were noted. Patient discharge occurred
on the day after the procedure in three patients and four
days after stent placement in one patient. Limited early
follow-up is encouraging.
Patient 1
Patient 1 was born with pulmonary atresia, ventricular
septal defect (VSD), and non-confluent pulmonary arter-
ies supplied by a patent ductus arteriosus and collateral
v ssels. Due to complications of prematurity, he was
maintained on prostaglandin infusion for an extended
period. At 5 months of age, pulmonary artery unifocal-
ization and placement of a 7 mm Dacron Hemashield
valveless conduit from the right ventricle to the unifo-
calized pulmonary artery confluence was performed. The
Fig. 1. The Palmaz Corinthian IQ stent, a new addition to the
interventional catheterization laboratory. A new cell design and
the addition of hinges connecting adjacent cells gives the stent
improved pre-deployment flexibility, facilitating its delivery
through tortuous anatomy.
Fig. 2. Patient 2. A Palmaz Corinthian IQ stent mounted on a 6
mm 3 2 cm Jupiter balloon catheter (solid arrow) is seen within
a 6 French delivery sheath. The tip of the sheath is in the
proximal right pulmonary artery (open arrow). The balloon cath-
eter tracks easily through the tightly curved delivery sheath,
demonstrating enhanced pre-deployment stent flexibility.
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large VSD was left open, and right ventricular (RV)
pressures remained systemic. Postoperative oxygen sat-
uration was 82% in room air. Over the next 8 months,
oxygen saturation slowly decreased to 60% secondary to
progressive conduit and proximal left pulmonary artery
(LPA) stenosis. Initial cardiac catheterization with bal-
loon angioplasty of the conduit and LPA was acutely
successful, however increasing cyanosis with echocar-
diographic evidence of conduit restenosis (proximal con-
duit diameter 1.9 mm, estimated conduit gradient 70–75
mm Hg) prompted repeat catheterization 3 months later.
Angiography confirmed severe proximal conduit stenosis
(Fig. 3A), and stent placement was recommended to
prolong the life span of the conduit. At 16 months of age
and 8 kg, a Palmaz Corinthian IQ 154 stent was placed in
the stenotic proximal conduit with immediate relief of
the stenosis (Fig. 3B) and improvement in systemic ox-
ygen saturation from 65–82%. Proximal conduit diame-
ter increased from 2 to 5.5 mm (275%) and the conduit
gradient decreased from 72 to 19 mm Hg after stent
placement. The RV pressures remained systemic pre- and
post-stent placement due to the large VSD. Fluoroscopy
time was 56.5 min. There were no complications. The
post-stent echocardiogram showed appropriate stent
placement within the conduit, a total gradient of 20–25
mm Hg across the RV outflow tract, and bi-directional
shunting through the large VSD. The patient was dis-
charged from the hospital on the day after the procedure.
At recent 5-month follow-up, oxygen saturation re-
mained acceptable at 74%. The conduit was patent by
Fig. 3. Patient 1. (A) Lateral right ventricu-
logram showing severe proximal conduit
stenosis (solid arrow). (B) Significant relief of
the stenosis is seen after stent placement
(open arrow). RV, right ventricle; PA, unifo-
calized pulmonary artery confluence.
TABLE I. Hemodynamic Data
Patient Diagnosis
RVp (mmHg) RVp:SBP Gradient (mmHg) SaO2 (%)
pre post pre post pre post pre post





89 82 1.0 1.0 72 19 65 82



















68 51 0.9 0.6 NA NA 99 98
LPA, left pulmonary artery; PA, pulmonary atresia; RPA, right pulmonary artery; RV, right ventricular; RVp, right ventricular pressure; RVp:SBP, right
ventricle to systemic arterial blood pressure ratio; SaO2, pulse oximetry; TOF, tetralogy of Fallot; VSD, ventricular septal defect; NA, not available.
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2-D echocardiography, however, accurate Doppler inter-
rogation of the conduit was impossible due to conduit
position in the chest.
Patient 2
Patient 2 presented at 9 months of age with pulmonary
atresia, VSD, and non-confluent pulmonary arteries sup-
plied by bilateral arterial ducts. At 11 months of age,
pulmonary artery unifocalization, fenestrated (5 mm)
closure of the VSD, and placement of a 13 mm aortic
homograft from the RV to the unifocalized pulmonary
artery confluence was performed. Postoperative RV pres-
sures remained systemic due to the fenestrated VSD.
Room air systemic oxygen saturation was 78% at hospi-
tal discharge. Due to progressive cyanosis, cardiac cath-
eterization was performed at 15 month of age. Severe
bilateral pulmonary artery stenosis was found and bal-
loon angioplasty was performed with early success. Four
months later, however, the patient presented with severe
ascites, peripheral edema, and hypoxemia (systemic ox-
ygen saturation 55–60%). Echocardiography showed
predominately right-to-left shunt through the VSD fen-
estration, a dilated RV with poor systolic function, and
severe, bilateral proximal pulmonary artery stenosis.
Cardiac catheterization confirmed severe right pulmo-
nary artery (RPA) and LPA stenosis (Fig. 4A,B). At 18
months of age and 7.4 kg, Palmaz Corinthian 185 and
155 stents were placed in the RPA and LPA, respec-
tively, with acute relief of the stenoses (Fig. 4C,D),
improvement in oxygen saturation to 88%, and resolution
of right ventricular failure. RPA diameter increased from
1.3 to 3.7 mm (285%) and LPA diameter increased from
1.9 to 3.7 mm (195%). Pressure gradients decreased from
50 to 15 mm Hg across the RPA and from 55 to 37 mm
Hg across the LPA. The RV pressures remained systemic
pre- and post-stent placement due to the large VSD
fenestration. Total fluoroscopy time was 172 min for the
placement of both stents. There were no complications.
Post-stent echocardiography showed normal RV systolic
function and predominately left-to-right shunting
through the VSD fenestration. The patient was dis-
charged on the following day.
At 7 month follow-up, systemic saturation was 89% in
room air and RV function was normal. Accurate Doppler
gradients through the stents could not be obtained.
Patient 3
Patient 3 underwent complete repair of tetralogy of
Fallot using a transannular patch and LPA angioplasty at
8 days of age after a persistent hypercyanotic spell. He
was readmitted at 5 months of age after echocardiogra-
phy showed progressive RV dysfunction with an esti-
mated RV pressure of 85 mm Hg. Cardiac catheterization
revealed severe LPA stenosis, a widely patent RPA,
systemic RV and distal RPA pressures, and severely
depressed RV function. At 5 months of age and 4.6 kg, a
Palmaz Corinthian IQ 154 stent was placed in the prox-
imal LPA with acute relief of the stenosis. The proximal
LPA diameter increased from 1.9 to 4.3 mm (210%). A
67 mm Hg gradient was present across the LPA before
Fig. 4. Patient 2. (A, B) Frontal right pulmo-
nary artery (RPA) and left pulmonary artery
(LPA) angiograms showing severe, bilateral,
pulmonary artery stenoses (solid arrows).
(C, D) Significant relief of the stenoses is
seen after stent placement (open arrows).
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stent placement, however, a post-stent gradient was not
obtained due to loss of distal wire position. Systolic RV
pressure was 95 (systemic pressure 85, RV:systemic ratio
1.1) before and 68 mm Hg (systemic pressure 82 mm Hg,
ratio 0.8) after stent placement. RV end-diastolic pres-
sure decreased from 23 to 13 mm Hg after stent place-
ment. Fluoroscopy time was 59.9 min and there were no
complications. The post-stent echocardiogram showed
appropriate stent placement and an estimated RV pres-
sure of 55 mm Hg. The patient was discharged 4 days
after the catheterization.
At 1 month follow-up, estimated RV pressure was
again systemic (90–95 mm Hg) with poor RV systolic
function on the echocardiogram. Cardiac catheterization
was performed, however the procedure was terminated
due to respiratory difficulty and acute metabolic acidosis
requiring intensive care management. No right heart
pressures were recorded due to patient instability. Further
evaluation revealed a pan-vasculitis that was treated with
steroids. Most recent follow-up, 3 months after stent
placement, showed an asymptomatic infant with signifi-
cantly improved RV function despite persistently ele-
vated RV pressures. Further hemodynamic evaluation is
planned.
Patient 4
Patient 4 was born with tetralogy of Fallot and the left
main coronary artery arising form the proximal right
coronary artery. A modified Blalock-Taussig shunt was
placed in infancy, and complete repair with placement of
a 19 mm RV to pulmonary artery homograft was per-
formed at 22 months of age. Routine echocardiogram at
31 months of age showed a dilated RV, near systemic
estimated RV pressures (65–70 mm Hg), and diminished
LPA blood flow. At 32 months of age and 11.1 kg,
cardiac catheterization showed near systemic RV pres-
sures and a nearly isolated LPA on angiography. Distal
LPA pressures could not be measured. A Palmaz Corin-
thian IQ 154 stent was placed in the nearly isolated,
proximal LPA with immediate relief of the stenosis.
Proximal LPA diameter was 4.8 mm after stent deploy-
ment and improved blood flow to the left lung was noted.
No post-stent gradient across the proximal LPA was
obtained due to loss of distal wire position. RV systolic
pressure decreased from 68 (systemic pressure 78, ratio
0.9) to 51 mm Hg (systemic pressure 80 mm Hg, ratio
0.6) after stent placement. Fluoroscopy time was 55.2
min and there were no complications. Post-stent echo-
cardiography revealed good stent placement and an esti-
mated RV pressure of 55 mm Hg. The patient was
discharged on the day after the procedure.
DISCUSSION
Congenital or postoperative right ventricular (RV) out-
flow obstruction causes significant morbidity in children
with heart disease. In patients with RV to pulmonary
artery conduits, distal pulmonary artery obstruction ex-
acerbates conduit valve insufficiency and causes RV
volume overload. Postoperative conduit obstruction leads
to RV pressure overload and ventricular dysfunction.
These difficulties are successfully palliated in older chil-
dren and adults with the use of balloon expandable stents
[3–8].
As the complete surgical repair of various forms of
congenital heart disease at a very young age becomes
more common, postoperative right ventricular outflow
obstruction in infants is encountered more frequently.
Balloon angioplasty alone of peripheral pulmonary artery
and conduit stenoses has only limited success [11–14],
and surgical management is often required. In our series,
balloon angioplasty achieved transient success (,5
months) in Patients 1 and 2, and was unsuccessful in
Patients 3 and 4. Surgical management is, however,
occasionally very high risk (Patients 1–3) or undesirable
due to multiple previous or anticipated surgical proce-
dures (Patients 1 and 4). Stent placement, therefore,
offers an attractive alternative to balloon angioplasty or
surgery in this select group of patients.
Although balloon expandable stents have been used
with some success in infants [9], limitations of the orig-
inal Palmaz stent have prevented its widespread use in
this age group. All sizes of the original Palmaz stent are
inflexible, making them difficult to advance through a
tightly curved delivery sheath. The Palmaz P128 and
P188 stents are delivered through 9 French sheaths (8
French with front-loading) that are too large for infants.
Although the Palmaz P154 stent may be delivered
through a 6 French sheath, it is inflexible and tracks
poorly over a wire, especially in infants and small chil-
dren.
An ideal stent for use in infants would be flexible,
deployable through a small sheath, and have radial
strength similar to that of the original Palmaz stent. The
Palmaz Corinthian stent, recently approved for use in
adult hepatobiliary obstruction, has these characteristics.
It is available as Palmaz Corinthian and Palmaz Corin-
thian IQ product lines. A new cell design and the addition
of hinges to provide flex points between adjacent cells
(Fig. 1) gives Palmaz Corinthian stents improved pre-
deployment flexibility [10]. They can be delivered on
high-pressure balloon catheters through 6 French sheaths
in vivo, and most recently through a 5 French system in
vitro. Radial strength is equal to (Palmaz Corinthian) or
greater than (Palmaz Corinthian IQ) that of the original
Palmaz P154 stent [10], an important characteristic for
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stents deployed in conduit and peripheral pulmonary
artery stenoses.
An additional difficulty encountered with stent place-
ment in infants and small children is that a relative
stenosis of the stented vessel may occur as the patient
grows, requiring future surgical intervention to relieve
the stenosis. For this reason, stents that are not expand-
able to near adult vessel diameter are generally not used
in infants at our institution. Stent placement is consid-
ered, however, when the patient’s condition puts him or
her at very high risk to undergo surgical correction with
cardiopulmonary bypass, or when surgery is undesirable
due to multiple previous or anticipated surgical proce-
dures. In each of our patients, the cardiac surgeon be-
lieved the risk associated with surgical relief of RV
outflow obstruction using cardiopulmonary bypass was
too great, and for this reason stent placement was per-
formed.
The original Palmaz P128 and P188 stents are expand-
able to adult vessel diameter, but require large delivery
sheaths for deployment as previously discussed. The
Palmaz P154 stent, deployable through a 6 French
sheath, can be maximally expanded to 11 mm [10] to
achieve a cross sectional area (CSA) of 0.95 cm2. The
new design of the Palmaz Corinthian stents decreases
stent foreshortening and allows for a greater final stent
diameter at maximum expansion. The Palmaz Corinthian
IQ 154 and 184 stents can be maximally expanded to 13
mm with a stent CSA of 1.33 cm2, a 40% increase in
CSA compared to the Palmaz P154. Maximum expan-
sion of Palmaz Corinthian stents is not, however, ap-
proved by the Federal Drug Administration.
In summary, our initial experience using Palmaz
Corinthian stents in infants and small children with con-
genital heart disease is encouraging. The Palmaz Corin-
thian stent has superior flexibility, equal or improved
radial strength, ease of delivery through a small sheath,
and greater maximum expanded diameter and cross sec-
tional area when compared to the original Palmaz stent.
These characteristics make Palmaz Corinthian stents a
reasonable alternative for use in a select group of infants
and small children who are at high risk for surgical
treatment of postoperative right ventricular outflow ob-
struction.
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